BPBT
ARCT icon

Boston Private Bank & Trust’s Arcturus Therapeutics ARCT Stock Holding History

Boston Private Bank & Trust’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-286
Closed -$7K – 1067
2014
Q4 		$7K Buy
+286
New +$9.1K ﹤0.01% 906

Other funds holding ARCT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boston Private Bank & Trust's ARCT Position: Q1 2015 in Review

Boston Private Bank & Trust sold out of Arcturus Therapeutics (ARCT) in Q1 2015, closing a stake of 286 shares — an estimated $7K sold.

Boston Private Bank & Trust first reported a position in ARCT in Q4 2014 and held it in 1 quarter. The position peaked at $7K in Q4 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q1 2015.

  • Boston Private Bank & Trust reported no remaining Arcturus Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Boston Private Bank & Trust sold 286 Arcturus Therapeutics shares in Q1 2015, an estimated $7K.
  • Boston Private Bank & Trust first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 1 quarter.
  • Boston Private Bank & Trust's Arcturus Therapeutics position peaked at $7K in Q4 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.